No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
UAE – State-owned Dubai Academic Health Corporation (DAHC), AXDEV Group, and Pfizer have signed a public-private partnership for improving chronic disease management. It follows the emerging trends of world-class healthcare…
Read More
NIGERIA – The National Primary Health Care Development Agency (NPHCDA) has launched the Optimised Client-Centred Services (OptiCCs), to avert maternal health challenges in the country. The Executive Director, NPHCDA, Dr…
Read More
BELGIUM — The European Federation of Pharmaceutical Industries and Associations (EFPIA), based in Brussels, has urged the European Commission to conduct a thorough assessment of the impact of its upcoming…
Read More
USA — The patent dispute between Supernus and Sage Chemical over the Parkinson’s drug Apokyn has caught the attention of the Federal Trade Commission (FTC), which has expressed concerns over…
Read More
USA — Novo Nordisk’s Ozempic, a treatment for type 2 diabetes and off-label for weight loss, is no longer on the FDA’s drug shortage list after months of limited supply.…
Read More
UAE – The Mohammed bin Rashid University of Medicine and Health Sciences (MBRU) has officially received its second accreditation from the Saudi Commission for Health Specialties (SCFHS) in the Kingdom…
Read More
USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…
Read More
KENYA – The Ministry of Health is collaborating with Japanese engineers on a Vaccination Management System (VMS) that will include biometric technologies. This system aims to improve the survival rates…
Read More
AFRICA – The COVID Treatment Quick Start Consortium has announced that the governments of Zambia, Laos, Malawi and Rwanda have received shipments of PAXLOVID (nirmatrelvir/ritonavir), Pfizer’s COVID-19 oral treatment. Partners…
Read More
USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…
Read More